Louis Nabors

Professor

The University of Alabama

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Louis Nabors is a Professor at the University of Alabama at Birmingham, USA. His research primarily focuses on glioblastoma, encompassing areas such as molecular correlates of treatment responses, clinical trial design, and the exploration of novel therapeutic strategies. Recent publications include updates to the NCCN CNS Tumor Guidelines and investigations into the prognostic implications of imaging biomarkers.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Natalia Filippova

Assistant Professor

The University of Alabama

UNITED STATES

View details

Craig Horbinski

Northwestern University

UNITED STATES

View details

Ashley Harms

Associate Professor

The University of Alabama

UNITED STATES

View details

Peter King

The University of Alabama

UNITED STATES

View details

Benjamin M Ellingson

University of California, Los Angeles

UNITED STATES

View details

Karisa Schreck

Assistant Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Sarah C. Markt

Case Western Reserve University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Louis Nabors

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

NCCN CNS Tumor Guidelines Update for 2024

Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma

Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma

The road we travel

NCCN CNS Tumor Guidelines Update for 2023

Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

Targeting the TREM1-positive myeloid microenvironment in glioblastoma

Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials

SRI‐42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide‐induced neuroinflammation

Data Matching to Support Analysis of Cancer Epidemiology Among Veterans Compared With Non-Veteran Populations—An Exemplar in Brain Tumors

Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors

Mapping uncharted territory: a gene expression signature for precision glioblastoma therapeutics

A troublesome burden, the amplification of EGFR in glioblastoma!

Collaborators (7)

Natalia Filippova

Craig Horbinski

Ashley Harms

Peter King

Benjamin M Ellingson

Karisa Schreck

Sarah C. Markt

Make your next move.